A phase II study of weekly docetaxel as salvage chemotherapy for advanced gastric cancer

This publication has 14 references indexed in Scilit:

• Mitomycin C continuous infusion as salvage chemotherapy in pretreated patients with advanced gastric cancer
  Anti-Cancer Drugs, 1999
• Weekly docetaxel in minimally pretreated cancer patients: A dose-escalation study focused on feasibility and cumulative toxicity of long-term administration
  Annals of Oncology, 1999
• Intensive weekly chemotherapy for locally advanced gastric cancer using 5-fluorouracil, cisplatin, epidoxorubicin, 6S-leucovorin, glutathione and filgrastim: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD).
  British Journal of Cancer, 1998
• Phase I trial of docetaxel administered by weekly infusion in patients with advanced refractory cancer.
  Journal of Clinical Oncology, 1998
• Weekly docetaxel and concomitant boost radiotherapy for non-small cell lung cancer. A phase I/II dose escalation trial
  European Journal Of Cancer, 1998
• Phase II study of paclitaxel in pretreated advanced gastric cancer
  Anti-Cancer Drugs, 1998
• Medical management of advanced gastric cancer
  Cancer Treatment Reviews, 1998
• Intensive weekly chemotherapy for advanced gastric cancer using fluorouracil, cisplatin, epi-doxorubicin, 6S-leucovorin, glutathione, and filgrastim: a report from the Italian Group for the Study of Digestive Tract Cancer.
  Journal of Clinical Oncology, 1997
• Weekly high-dose 5-fluorouracil and folinic acid as salvage treatment in advanced gastric cancer
  Annals of Oncology, 1994
• Docetaxel (TaxotereTM) in advanced gastric cancer: results of a phase II clinical trial. EORTC Early Clinical Trials Group
  British Journal of Cancer, 1994